SR
Steven B Ratoff
Director

Steven B Ratoff insider trades: Eagle Pharmaceuticals (EGRX) stock buys and sales

Director, Eagle Pharmaceuticals Last trade Dec 13, 2016 42 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2005
6
Companies
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Steven reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 13, 2016EGRX↓ Sell$750K
Apr 3, 2014EGRX↑ Buy$51K
Dec 11, 2009NVD↑ Buy$159K
Aug 28, 2007NVD↑ Buy$4K
Aug 24, 2007NVD↑ Buy$4K
Aug 23, 2007NVD↑ Buy$26K
Aug 22, 2007NVD↑ Buy$3K
Aug 21, 2007NVD↑ Buy$30K
Aug 20, 2007NVD↑ Buy$15K
Dec 27, 2006TPTX↑ Buy$346K
Apr 19, 2006NVD↑ Buy$204K
May 19, 2005AXYX↑ Buy$299K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Steven B Ratoff's insider trades

Steven B Ratoff is a director at Eagle Pharmaceuticals (EGRX). Since May 19, 2005, Steven has reported 11 open-market purchases worth $1.1M and 1 sale worth $750K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (26 filings), option exercises (4 filings), conversions (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EGRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.